Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Characterizing soluble immune checkpoint molecules and TGF-β1,2,3 in pleural effusion of malignant pleural mesothelioma

    The clinical impact of soluble molecules in pleural effusion (PE) is unclear in patients with malignant pleural mesothelioma (MPM). In this single-center, retrospective, observational study, we assessed solubl...

    Riki Okita, Tomoya Senoo, Yuka Mimura-Kimura, Yusuke Mimura in Scientific Reports (2024)

  2. No Access

    Article

    Effects of tumor-infiltrating CD8+ T cells, PD1/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra-pleural pneumonectomy

    Programmed cell death protein-1 (PD1), PD1 ligand 1 (PD-L1), and human leukocyte antigen (HLA) class I molecule play pivotal roles in T cell-induced anti-tumor immunity; however, the clinical impact of these p...

    Riki Okita, Yuka Mimura-Kimura, Nobutaka Kawamoto in Cancer Immunology, Immunotherapy (2023)

  3. Article

    Open Access

    Preoperative neutrophil-to-lymphocyte ratio correlates with PD-L1 expression in immune cells of patients with malignant pleural mesothelioma and predicts prognosis

    We assessed the prognostic value of five complex inflammatory and nutritional parameters, namely neutrophil-to-lymphocyte ratio (NLR), prognostic nutritional index (PNI), C-reactive protein-to-NLR ratio (C/NLR...

    Riki Okita, Nobutaka Kawamoto, Masanori Okada, Hidetoshi Inokawa in Scientific Reports (2023)

  4. No Access

    Article

    PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer

    Immunocheckpoint inhibitors targeting the programmed cell death-1 (PD-1) and PD-1 ligand 1 (PD-L1) axis have shown promising results in patients with non-small-cell lung cancer (NSCLC). Recent research has sho...

    Riki Okita, Ai Maeda, Katsuhiko Shimizu, Yuji Nojima in Cancer Immunology, Immunotherapy (2017)

  5. Article

    Open Access

    Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report

    Pneumatosis intestinalis (PI) is defined as the presence of gas in the bowel wall and is a relatively rare finding. PI has been associated with various pathological conditions and medications. Although several...

    Ai Maeda, Masao Nakata, Katsuhiko Shimizu in World Journal of Surgical Oncology (2016)

  6. No Access

    Article

    MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer

    MHC class I chain-related molecule A and B (MICA/B) are NK group 2 member D (NKG2D) ligands, which are broadly expressed in transformed cells. Both DNA damage-induced ataxia-telangiectasia-mutated (ATM)- and ...

    Riki Okita, Takuro Yukawa, Yuji Nojima, Ai Maeda in Cancer Immunology, Immunotherapy (2016)

  7. Article

    Open Access

    Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer

    The maximal standardized uptake value (SUVmax) of pulmonary lesions on dual-time-point (DTP) fluorodeoxyglucose positron emission tomography (FDG-PET) has been shown to be useful for differentiation between ma...

    Katsuhiko Shimizu, Riki Okita, Shinsuke Saisho, Takuro Yukawa in Annals of Nuclear Medicine (2015)

  8. Article

    Open Access

    Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer

    The immunological status, consisting of “inflammation status” and “nutritional condition,” is important for the survival of patients with various cancers, including non-small cell lung cancer (NSCLC). The neut...

    Katsuhiko Shimizu, Riki Okita, Shinsuke Saisho in World Journal of Surgical Oncology (2015)

  9. Article

    Open Access

    Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy

    Adjuvant chemotherapy after the resection of stage IB-IIIA non-small cell lung cancer (NSCLC) is now the standard of care based on large-scale phase III trials and a meta-analysis. However, chemotherapy has pl...

    Katsuhiko Shimizu, Takuro Yukawa, Riki Okita in World Journal of Surgical Oncology (2015)

  10. Article

    Open Access

    Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma

    The maximal standardized uptake value (SUVmax) on fluorodeoxyglucose-positron emission tomography (FDG-PET) for primary tumors is correlated with clinicopathological and prognostic factors in patients with non...

    Katsuhiko Shimizu, Ai Maeda, Takuro Yukawa in World Journal of Surgical Oncology (2014)

  11. Article

    Open Access

    A case report of intrapulmonary schwannoma

    A 38-year-old man without any symptoms was admitted to our institution because of an abnormal shadow found incidentally on a chest X-ray. Chest computed tomography showed a round mass in the lingular segment o...

    Takuro Yukawa, Katsuhiko Shimizu in General Thoracic and Cardiovascular Surgery (2014)

  12. No Access

    Article

    Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer

    The purpose of this study was to clarify the distribution of epidermal growth factor receptor (EGFR) mutations between primary tumors (PT) and metastatic lymph node (MLN) in patients with resected non-small cell ...

    Katsuhiko Shimizu, Takuro Yukawa, Yuji Hirami, Riki Okita in Targeted Oncology (2013)

  13. No Access

    Article

    Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum

    Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum is extremely rare. In this report, we present a case of a 53-year-old man with superior vena cava (SVC) syndrome who developed LCN...

    Ai Maeda, Masao Nakata, Kouichiro Yasuda in General Thoracic and Cardiovascular Surgery (2013)

  14. No Access

    Article

    Role of 2-[18F]fluoro-2-deoxyglucose positron emission tomography in preoperative management of solid-type small-sized lung cancer

    2-[18F]Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) is routinely used for the diagnosis of primary lung cancer. However, the role of FDG-PET in the diagnosis and staging of small-sized lung can...

    Shinsuke Saisho, Koichiro Yasuda, Ai Maeda, Takuro Yukawa in Annals of Nuclear Medicine (2013)

  15. No Access

    Article

    High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis

    Reactive oxygen species (ROS) are strongly implicated in melanoma development, and treatment with antioxidants has shown efficacy in suppressing malignant transition and progression. Here, we investigated the ...

    Dimitrios Mougiakakos, Riki Okita, Takashi Ando in Journal of Molecular Medicine (2012)

  16. No Access

    Article

    Successful perioperative management for a breast cancer patient with Bernard–Soulier syndrome

    We herein report the first case of a Bernard–Soulier syndrome (BSS) patient undergoing a surgical procedure for breast cancer. BSS is a rare hereditary thrombocytopathy associated with defects of the platelet ...

    Riki Okita, Jun Hihara, Kazuo Konishi, Akihiko Osaki, Kingo Fujimura in Breast Cancer (2012)

  17. No Access

    Article

    Successful management of multiple esophagorespiratory fistulas using two types of stent: Report of a case

    We herein describe a 41-year-old man with esophageal cancer who developed three esophagorespiratory fistulas (ERFs) that were successfully treated using one esophageal and three airway stents. A self-expandabl...

    Yoichi Hamai, Jun Hihara, Manabu Emi, Riki Okita, Katsuhiko Shimizu in Surgery Today (2011)

  18. No Access

    Article

    Suggestive synchronous triple squamous cell carcinoma of the lung in the same lobe

    We report a case of suggestive synchronous triple squamous cell carcinoma (Sq) of the lung that occurred in the same lobe. Under a clinical diagnosis of triple lung cancer, lobectomy was performed. Pathologica...

    Riki Okita, Katsuhiko Shimizu in General Thoracic and Cardiovascular Surgery (2010)

  19. No Access

    Article

    Use of entecavir to prevent hepatitis B virus reactivation during cytotoxic chemotherapy for solid malignancy

    Reactivation of hepatitis B virus (HBV) infection is a frequent complication of cytotoxic chemotherapy that includes steroids. International studies have shown that lamivudine reduces the incidence and severit...

    Riki Okita, Mamoru Takahashi, Hiroyuki Narahara in Clinical Journal of Gastroenterology (2009)

  20. No Access

    Article

    Pharmacokinetic analysis of a combined chemoendocrine treatment with paclitaxel and toremifene for metastatic breast cancer

    Multidrug resistance protein could be a target for improving the efficacy of paclitaxel (PXL). Toremifene (TOR) may moderate P-gp-related drug resistance in vitro. Some P-gp moderators may change the pharmacok...

    Toshiaki Saeki, Atsushi Okita, Kenjiro Aogi, Tomokazu Kakishita in Breast Cancer (2009)

previous disabled Page of 2